Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of gemcitabine versus cisplatin concurrent with radiotherapy for locally advanced head and neck squamous cell carcinoma
ISRCTN52466525Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gemcitabine and cisplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Primary endpoint: Toxicity. Started Jun 2007; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on ISRCTN52466525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN52466525.